Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis
- PMID: 9367403
- PMCID: PMC2265498
- DOI: 10.1111/j.1365-2249.1997.tb08318.x
Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis
Abstract
Soluble Leishmania antigen (SLA) from both developmental stages of L. major (L. major MRHO/IR/75/ER) were prepared. Three and five subfractions of SLA from amastigote and promastigote were obtained by fast protein liquid chromatography (FPLC), respectively. Biochemical analyses and comparison of amastigote and promastigote SLA were done. The biochemical analyses revealed that the first fraction of L. major amastigote possesses a distinct band on its electrophoretic mobility pattern corresponding to a position of 24 kD, and it has enzymatic activity with characteristics of a cysteine proteinase. The isolated fractions of amastigote were tested for induction of proliferation, interferon-gamma (IFN-gamma) and IL-4 production in cultures of peripheral blood mononuclear cells (PBMC) from individuals who had recovered and also chronic patients of cutaneous leishmaniasis caused by L. major. The cells of recovered individuals compared with chronic cases proliferated profoundly in response to the first fraction of amastigote SLA. In all recovered individuals, the IFN-gamma, but not IL-4, was secreted in response to stimulation with the first fraction of amastigote SLA. In chronic cutaneous leishmaniasis, IFN-gamma was infrequently observed in response to stimulation by all three fractions of amastigote SLA, but secretion of IL-4 was observed. These data indicate that first fraction of amastigote SLA is a strong inducer of primed human immune response to L. major, and may have a protective function.
Similar articles
-
Vaccination of BALB/c mice with Leishmania major amastigote-specific cysteine proteinase.Clin Exp Immunol. 2000 Apr;120(1):134-8. doi: 10.1046/j.1365-2249.2000.01160.x. Clin Exp Immunol. 2000. PMID: 10759774 Free PMC article.
-
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.Exp Parasitol. 1996 Nov;84(2):144-55. doi: 10.1006/expr.1996.0100. Exp Parasitol. 1996. PMID: 8932764
-
Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis.Clin Exp Immunol. 1994 Jun;96(3):410-5. doi: 10.1111/j.1365-2249.1994.tb06043.x. Clin Exp Immunol. 1994. PMID: 8004809 Free PMC article.
-
Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica.Clin Exp Immunol. 2003 May;132(2):316-22. doi: 10.1046/j.1365-2249.2003.02165.x. Clin Exp Immunol. 2003. PMID: 12699423 Free PMC article.
-
Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.Behring Inst Mitt. 1997 Feb;(98):153-9. Behring Inst Mitt. 1997. PMID: 9382736 Review.
Cited by
-
Computational analysis of cysteine proteases (Clan CA, Family Cl) of Leishmania major to find potential epitopic regions.Genomics Proteomics Bioinformatics. 2009 Sep;7(3):87-95. doi: 10.1016/S1672-0229(08)60037-6. Genomics Proteomics Bioinformatics. 2009. PMID: 19944381 Free PMC article.
-
DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant.PLoS Negl Trop Dis. 2014 Dec 11;8(12):e3391. doi: 10.1371/journal.pntd.0003391. eCollection 2014 Dec. PLoS Negl Trop Dis. 2014. PMID: 25500571 Free PMC article.
-
Vaccination of BALB/c mice with Leishmania major amastigote-specific cysteine proteinase.Clin Exp Immunol. 2000 Apr;120(1):134-8. doi: 10.1046/j.1365-2249.2000.01160.x. Clin Exp Immunol. 2000. PMID: 10759774 Free PMC article.
-
Insights into Leishmania Molecules and Their Potential Contribution to the Virulence of the Parasite.Vet Sci. 2021 Feb 20;8(2):33. doi: 10.3390/vetsci8020033. Vet Sci. 2021. PMID: 33672776 Free PMC article. Review.
-
Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.Infect Immun. 2000 Apr;68(4):1760-4. doi: 10.1128/IAI.68.4.1760-1764.2000. Infect Immun. 2000. PMID: 10722561 Free PMC article.
References
-
- Locksley RM, Louis JA. Immunology of leishmaniasis. Curr Opin Immunol. 1992;4:413–8. - PubMed
-
- Melby CP. Experimental leishmaniasis: review. Rev Infect Dis. 1991;13:1009–17. - PubMed
-
- Kemp M, Theander TG, Kharazmi A. The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example. Immunol Today. 1996;17:13–16. - PubMed
-
- Peters W, Killick-Kendrick R. III. New York: Academic Press; 1987. The leishmaniasis in biology and medicine clinical aspects and control.
-
- Modabber F. Development of vaccines against leishmaniasis. Scand 3. Infect Dis Supplement. 1990;76:72–78. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources